Introduction: The condition of decreased muscle mass and function in people with type 2 diabetes mellitus (DMT2) will lead to a significant effect on the decline in quality of life. A commonly found manifestation of sarcopenia is the presence of a decrease in the strength of the hand grip. Other research showed a significant inverse relationship between the strength of the hand grip and DMT2. But to date, there are still few studies that assess the factors that cause a decrease in the strength of the hand grip in DMT2 patients. This study aims to evaluate risk factors that are related to the strength of the decrease in the strength of the hand grip in patients with DMT2. Methods: Cross-sectional analytical research. The data was taken through interviews, physical examinations and data collection of laboratory examination results at the general polyclinic of the Tabanan Public Health Center II. The bivariate test used chi-square and the multivariate analysis with logistic regression was used in assessing the magnitude of influence between variables that have a meaningful relationship with HGS and looking for the magnitude of the adjusted odd ratio (AOR) value.  Results: The study discovered a strong correlation between age (p=0.002), body mass index (p=0.002), and fasting blood sugar levels (p=0.001) and hand grip strength. In the multivariate analysis, it was found that the relationship of age more than 50 years to the decrease in hand grip strength was greater than high fasting blood sugar levels, while no significant relationship was found on excess nutritional status in this multivariate analysis (p=0.44). Conclusion: Age, body mass index, and fasting blood sugar levels are the risk factors for decreased hand grip strength in type 2 diabetes mellitus patients.

Introduction: Malaria is a parasitic disease caused by blood protozoa of the Plasmodium genus transmitted through the bite of a female Anopheles mosquito. Indonesia is still an endemic area, especially in the eastern regions. About 40% of malaria cases in the world are caused by Plasmodium vivax. Tertiana or vivax malaria can cause relapse because it has a hypnozoite stage that is dormant in the liver. This case report will discuss a case of relapse vivax malaria with thrombocytopenia. Case Illustration: A 38-year-old man came to the emergency room consciously with a fever complaint since 4 days before entering the hospital. Fever occurred throughout the body, disappeared, accompanied by chills and sweating. On the second day the fever began to decrease somewhat but the next day the fever began to increase. The patient has a history of serving in Papua and contracted malaria 3 months before entering the hospital. While in Papua, the patient worked as a supporter for the 2021 PON event and malaria treatment was not complete. A complete blood examination found thrombocytopenia and microscopic examination of thin drops of the presence of ring-shaped Plasmodium vivax. The patient is diagnosed with vivax relapse malaria. The patient was treated with antimalarial therapy with DHP 4 tablets in a day for 3 days and primaquine 2 tablets in a day for 14 days. Monitoring therapy was done on the eighth day, with microscopic examination, and the result was negative malaria plasmodium. Conclusion: This case report discusses vivax relapse malaria and proper management to irradiate the hypnozoite stage which has an important role in the recurrence phase.